AU2002212632A1 - Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions - Google Patents

Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions

Info

Publication number
AU2002212632A1
AU2002212632A1 AU2002212632A AU1263202A AU2002212632A1 AU 2002212632 A1 AU2002212632 A1 AU 2002212632A1 AU 2002212632 A AU2002212632 A AU 2002212632A AU 1263202 A AU1263202 A AU 1263202A AU 2002212632 A1 AU2002212632 A1 AU 2002212632A1
Authority
AU
Australia
Prior art keywords
adducts
antibiotics
aqueous solutions
natural polysaccharide
polysaccharide polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212632A
Inventor
Piergiorgio Anzaghi
Rosanna Stefli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMA BIOTECH Ltd
Original Assignee
PHARMA BIOTECH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMA BIOTECH Ltd filed Critical PHARMA BIOTECH Ltd
Publication of AU2002212632A1 publication Critical patent/AU2002212632A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
AU2002212632A 2000-11-17 2001-11-16 Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions Abandoned AU2002212632A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000MI002478A IT1319666B1 (en) 2000-11-17 2000-11-17 ANTIBIOTICS ADDUCTS WITH NATURAL POLYESACCHARIDE POLYMERS IN FORMATS AQUEOUS SOLUTIONS.
ITMI200A002478 2000-11-17
PCT/IB2001/002172 WO2002040057A1 (en) 2000-11-17 2001-11-16 Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions

Publications (1)

Publication Number Publication Date
AU2002212632A1 true AU2002212632A1 (en) 2002-05-27

Family

ID=11446119

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212632A Abandoned AU2002212632A1 (en) 2000-11-17 2001-11-16 Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions

Country Status (4)

Country Link
EP (1) EP1335748A1 (en)
AU (1) AU2002212632A1 (en)
IT (1) IT1319666B1 (en)
WO (1) WO2002040057A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
DE10209822A1 (en) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of low molecular weight substances to a modified polysaccharide
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2925009A1 (en) * 1979-06-21 1981-01-08 Basf Ag PREPARATION FOR SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF
US4663316A (en) * 1985-06-28 1987-05-05 Warner-Lambert Company Antibiotic clathrates and pharmaceutical compositions thereof
IT1312110B1 (en) * 1999-05-18 2002-04-04 Istituto Biochimico Pavese Pha NATURAL ANTIBIOTIC-POLYESACCHARIDIC POLYMER ADDUCTS
JP2001058994A (en) * 1999-08-19 2001-03-06 Eisai Co Ltd Stabilized amoxicillin inclusion complex

Also Published As

Publication number Publication date
IT1319666B1 (en) 2003-10-23
ITMI20002478A1 (en) 2002-05-17
EP1335748A1 (en) 2003-08-20
WO2002040057A1 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU7647000A (en) Increasing the polysaccharide content in plants
AU1271201A (en) Azepinoindole derivatives, the production and use thereof
AU2509700A (en) Polysaccharide fibers
AU2001288720A1 (en) Implantable article
AU2001240473A1 (en) Variants with altered properties
AU2002232480A1 (en) Three-dimensional tissue having asymmetrical protrusions and methods for making the same
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001267181A1 (en) Polyubiquitin based hydrogel and uses thereof
MXPA01011475A (en) Aqueous superarsorbent polymer and methods of use.
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2002220473A1 (en) Toughened plastics and its preparation method
AU2002213767A1 (en) Tenacity plastic and its preparation method
AU2001285038A1 (en) Hydrophilic insoluble cellulose as rheological modifier in water-immiscible liquids
AU2001294030A1 (en) Fibre and its production
AU2001261442A1 (en) Polymer blends and articles produced therewith
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU2001251007A1 (en) Viscosified aqueous fluids and viscosifier therefor
AU2001267171A1 (en) Modified xylanases exhibiting increased thermophilicity and alkalophilicity
AU4375799A (en) Acrylic polymers in substantially aqueous suspensions
AU2002361337A1 (en) Amphoteric polysaccharide, composition and use
AU2011501A (en) Benzimidazoles, production thereof and the use thereof as antithrombotic
AU5991400A (en) Manometer with direct passage
AUPR218000A0 (en) Polymer gels and their preparation
AU2002212632A1 (en) Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions